Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,674
archived clinical trials in
Skin Cancer

Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
A Multicenter, Open-label, Dose-escalation, Phase I Study of TAK-733, an Oral MEK Inhibitor, in Adult Patients With Advanced Nonhematologic Malignancies
Status: Enrolling
Updated:  10/4/2012
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
A Multicenter, Open-label, Dose-escalation, Phase I Study of TAK-733, an Oral MEK Inhibitor, in Adult Patients With Advanced Nonhematologic Malignancies
Status: Enrolling
Updated: 10/4/2012
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
A Multi-Center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-Arterial Temozolomide for Patients With Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion
Status: Enrolling
Updated:  10/17/2012
Moffitt Cancer Center
mi
from
Tampa, FL
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
A Multi-Center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-Arterial Temozolomide for Patients With Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion
Status: Enrolling
Updated: 10/17/2012
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
A Multi-Center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-Arterial Temozolomide for Patients With Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion
Status: Enrolling
Updated:  10/17/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
A Multi-Center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-Arterial Temozolomide for Patients With Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion
Status: Enrolling
Updated: 10/17/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
A Multi-Center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-Arterial Temozolomide for Patients With Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion
Status: Enrolling
Updated:  10/17/2012
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
A Multi-Center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-Arterial Temozolomide for Patients With Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion
Status: Enrolling
Updated: 10/17/2012
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Los Angeles, CA
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Miami, FL
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Athens, GA
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Athens, GA
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Chicago, IL
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Hazard, KY
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Hazard, KY
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Boston, MA
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Bridgewater, NJ
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Santa Fe, NM
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Santa Fe, NM
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Brooklyn, NY
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Chapel Hill, NC
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Philadelphia, PA
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Fort Worth, TX
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
American Fork, UT
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
American Fork, UT
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Seattle, WA
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
A Phase 2 Study of Marqibo in Patients With Metastatic Uveal Melanoma
Status: Enrolling
Updated:  1/15/2013
University of California at Los Angeles
mi
from
Los Angeles, CA
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
A Phase 2 Study of Marqibo in Patients With Metastatic Uveal Melanoma
Status: Enrolling
Updated: 1/15/2013
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
A Phase 2 Study of Marqibo in Patients With Metastatic Uveal Melanoma
Status: Enrolling
Updated:  1/15/2013
University of Colorado, Denver
mi
from
Denver, CO
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
A Phase 2 Study of Marqibo in Patients With Metastatic Uveal Melanoma
Status: Enrolling
Updated: 1/15/2013
University of Colorado, Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
A Phase 2 Study of Marqibo in Patients With Metastatic Uveal Melanoma
Status: Enrolling
Updated:  1/15/2013
Thomas Jefferson University
mi
from
Philadelphia, PA
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
A Phase 2 Study of Marqibo in Patients With Metastatic Uveal Melanoma
Status: Enrolling
Updated: 1/15/2013
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
A Phase 2 Study of Marqibo in Patients With Metastatic Uveal Melanoma
Status: Enrolling
Updated:  1/15/2013
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
A Phase 2 Study of Marqibo in Patients With Metastatic Uveal Melanoma
Status: Enrolling
Updated: 1/15/2013
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp
Status: Enrolling
Updated:  1/23/2013
University of Texas Health Science Center of Houston Dermatology Clinic
mi
from
Houston, TX
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp
Status: Enrolling
Updated: 1/23/2013
University of Texas Health Science Center of Houston Dermatology Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors
A Pilot Open-Label Study to Examine the Safety and Efficacy of Oral LDE225 in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma Who Have Been Previously Treated With Non-LDE225 Smoothened Inhibitor(s)
Status: Enrolling
Updated:  1/28/2013
Stanford University Cancer Institute
mi
from
Stanford, CA
Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors
A Pilot Open-Label Study to Examine the Safety and Efficacy of Oral LDE225 in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma Who Have Been Previously Treated With Non-LDE225 Smoothened Inhibitor(s)
Status: Enrolling
Updated: 1/28/2013
Stanford University Cancer Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Montefiore Medical Center
mi
from
Bronx, NY
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Oregon Health and Science University
mi
from
Portland, OR
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated:  2/18/2013
Huntsman Cancer Institute
mi
from
Salt Lake, UT
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Status: Enrolling
Updated: 2/18/2013
Huntsman Cancer Institute
mi
from
Salt Lake, UT
Click here to add this to my saved trials
Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
Experience of Patients With Non-Melanoma Skin Cancer of the Head and Neck Undergoing Mohs Surgery
Status: Enrolling
Updated:  2/25/2013
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
Experience of Patients With Non-Melanoma Skin Cancer of the Head and Neck Undergoing Mohs Surgery
Status: Enrolling
Updated: 2/25/2013
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology
Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H&E Histology
Status: Enrolling
Updated:  2/26/2013
Abramsonc Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology
Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H&E Histology
Status: Enrolling
Updated: 2/26/2013
Abramsonc Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Randomized Control Trial of Sun Protection Interventions for Operating Engineers
A Randomized Control Trial of Sun Protection Interventions for Operating Engineers
Status: Enrolling
Updated:  3/1/2013
University of Michigan, School of Nursing
mi
from
Ann Arbor, MI
A Randomized Control Trial of Sun Protection Interventions for Operating Engineers
A Randomized Control Trial of Sun Protection Interventions for Operating Engineers
Status: Enrolling
Updated: 3/1/2013
University of Michigan, School of Nursing
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Novel Treatment for Metastatic Melanoma
In Situ Photoimmunotherapy: A Tumor Directed Treatment for Advanced Melanoma With Cutaneous Metastases
Status: Enrolling
Updated:  3/26/2013
Northwestern University, Feinberg School of Medicine, Department of Dermatology
mi
from
Chicago, IL
A Novel Treatment for Metastatic Melanoma
In Situ Photoimmunotherapy: A Tumor Directed Treatment for Advanced Melanoma With Cutaneous Metastases
Status: Enrolling
Updated: 3/26/2013
Northwestern University, Feinberg School of Medicine, Department of Dermatology
mi
from
Chicago, IL
Click here to add this to my saved trials
Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery
Biomarkers of Response and Resistance to Sequential B-RAF and MEK Targeted Therapy in a Pre-Surgical Model of Advanced, Operable Melanoma
Status: Enrolling
Updated:  3/29/2013
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery
Biomarkers of Response and Resistance to Sequential B-RAF and MEK Targeted Therapy in a Pre-Surgical Model of Advanced, Operable Melanoma
Status: Enrolling
Updated: 3/29/2013
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients
Melanoma Peptide-Loaded Dendritic Cell Vaccine in HLA-A*0201 Patients With Stage IV Melanoma: A Phase II Randomized Trial to Compare Vaccination With and Without Cyclophosphamide Treatment.
Status: Enrolling
Updated:  7/5/2013
Baylor University Medical Center
mi
from
Dallas, TX
Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients
Melanoma Peptide-Loaded Dendritic Cell Vaccine in HLA-A*0201 Patients With Stage IV Melanoma: A Phase II Randomized Trial to Compare Vaccination With and Without Cyclophosphamide Treatment.
Status: Enrolling
Updated: 7/5/2013
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated:  7/18/2013
The Emory Clinic
mi
from
Atlanta, GA
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated: 7/18/2013
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated:  7/18/2013
Emory University Hospital
mi
from
Atlanta, GA
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated: 7/18/2013
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Birmingham, AL
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Chandler, AZ
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Escondido, CA
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Escondido, CA
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Chino, CA
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Los Angeles, CA
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Colorado Springs, CO
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Washington,
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Gainesville, FL
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Aurora, IL
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Aurora, IL
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Iowa City, IA
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Baltimore, MD
Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials